Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06323213 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety Study of 610 in Patients With Severe Asthma

Name: Efficacy and Safety Study of 610 in Patients With Severe Asthma — clinical trial record (NCT06323213)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Started2024-06-24

View on ClinicalTrials.gov ↗

Amendment history

2026-01-04

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Primary completion date2026-06→2027-02

Completion date2026-09→2027-09

Start dateestimated 2024-04→confirmed 2024-06-24

Study sites0→1

2024-03-14

Original filing

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

22 trials monitored

See all monitored trials

Asthma

918 trials monitored

See 29 trials at risk

The primary objective of the study is to evaluate the efficacy and safety of 610 in Chinese adults with severe asthma.

Trial Details

NCT Number	NCT06323213
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Asthma
Enrollment	480 participants
Start Date	2024-06-24
Primary Completion	2027-02 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-07